Normunity

Biotechnology Research • United States • 21-50 Employees

Company overview

Headquarters	United States
Phone number	+12039936580
Website	normunity.com
Employees	21-50
Socials

Key Contacts at Normunity

Jeff D Colbert

Senior Director Of Immunology And Oncology

Suzanne Bauer

Associate Director, Administration & Operations

Normunity Email Formats

Normunity uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@normunity.com), used 50% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@normunity.com	50%
{first name}.{last name}	john.doe@normunity.com	50%

About Normunity

Normunity is a biotechnology company creating novel anti-cancer therapies that address untapped biology at the interface of the immune system and the tumor to target mechanisms that impact tumor growth and circumvent immune surveillance and tumor clearance. The company is using these novel targets to build a pipeline of anti-cancer medicines, including therapeutic antibodies, bispecific antibodies, and payload-carrying biologics. The company’s lead program, NRM‑823, is a T cell engager with tumor-specific targeting for multiple solid tumors and is expected to enter the clinic in 2025. Normunity is located in Boston, MA, and New Haven, CT.

Normunity revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$46,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	$140,000,000